MX349572B - Parche no acuoso. - Google Patents

Parche no acuoso.

Info

Publication number
MX349572B
MX349572B MX2013013121A MX2013013121A MX349572B MX 349572 B MX349572 B MX 349572B MX 2013013121 A MX2013013121 A MX 2013013121A MX 2013013121 A MX2013013121 A MX 2013013121A MX 349572 B MX349572 B MX 349572B
Authority
MX
Mexico
Prior art keywords
lidocaine
aqueous patch
aqueous
rubefaction
polyalcohol
Prior art date
Application number
MX2013013121A
Other languages
English (en)
Other versions
MX2013013121A (es
Inventor
Tatsuya Mori
Naoyuki Saida
Original Assignee
Itochu Chemical Frontier Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47138899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX349572(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Itochu Chemical Frontier Corp filed Critical Itochu Chemical Frontier Corp
Publication of MX2013013121A publication Critical patent/MX2013013121A/es
Publication of MX349572B publication Critical patent/MX349572B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Botany (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Parches no acuosos que comprenden lidocaína, que no se disuelven y están presentes en un estado cristalino, tienen mala permeabilidad a la piel. Por lo tanto, parches no acuosos tienen una alta concentración de lidocaína. Se señala que la lidocaína tiene un efecto adverso sobre el corazón. El uso prolongado de una alta concentración de lidocaína causa efectos secundarios, tal como choque, rubor y sensación de irritación. Preparaciones externas que comprenden más de 5% en masa de la lidocaína se designan como fármacos poderosos, y no pueden usarse como medicina familiar (sin prescripción) Se proporcionan un parche no acuoso que es efectivo para aliviar el dolor muscular, el parche no acuoso que comprende lidocaína y/o su reactivo, y un agente de disolución compuesto de un ácido orgánico y un polialcohol, que están contenidos en una base.
MX2013013121A 2011-05-10 2011-05-10 Parche no acuoso. MX349572B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2011/060781 WO2012153396A1 (ja) 2011-05-10 2011-05-10 非水性貼付剤

Publications (2)

Publication Number Publication Date
MX2013013121A MX2013013121A (es) 2014-08-26
MX349572B true MX349572B (es) 2017-08-03

Family

ID=47138899

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017009966A MX368747B (es) 2011-05-10 2011-05-10 Parche no acuoso de lidocaína y un agente de disolución que comprende un ácido orgánico y un polialcohol que están contenidos en un emplaste para usarse en el tratamiento de dolor muscular a través de la piel.
MX2013013121A MX349572B (es) 2011-05-10 2011-05-10 Parche no acuoso.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2017009966A MX368747B (es) 2011-05-10 2011-05-10 Parche no acuoso de lidocaína y un agente de disolución que comprende un ácido orgánico y un polialcohol que están contenidos en un emplaste para usarse en el tratamiento de dolor muscular a través de la piel.

Country Status (9)

Country Link
US (2) US9283174B2 (es)
EP (2) EP2708229B1 (es)
JP (1) JP5856153B2 (es)
BR (2) BR112013028802B1 (es)
CA (1) CA2835595C (es)
ES (1) ES2743524T3 (es)
MX (2) MX368747B (es)
TW (1) TWI543761B (es)
WO (1) WO2012153396A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925264B2 (en) * 2011-05-10 2018-03-27 Itochu Chemical Frontier Corporation Non-aqueous patch
MX368747B (es) 2011-05-10 2019-10-14 Itochu Chemical Frontier Corp Parche no acuoso de lidocaína y un agente de disolución que comprende un ácido orgánico y un polialcohol que están contenidos en un emplaste para usarse en el tratamiento de dolor muscular a través de la piel.
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
JP6021269B2 (ja) 2011-09-27 2016-11-09 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤
JP6222521B2 (ja) * 2013-11-28 2017-11-01 荒川化学工業株式会社 合わせガラス用中間膜および合わせガラス
CN104188939B (zh) * 2014-08-20 2017-07-04 北京泰德制药股份有限公司 一种含有利多卡因或其药用盐的局部外用贴片剂
AU2016312038A1 (en) * 2015-08-24 2018-03-15 Itochu Chemical Frontier Corporation Non-aqueous patch comprising lidocaine
JP6209749B2 (ja) * 2015-12-10 2017-10-11 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤
JP7058856B2 (ja) * 2016-08-12 2022-04-25 株式会社サクラクレパス 粘着付与剤含有光硬化性人工爪組成物
US10828264B2 (en) 2016-09-16 2020-11-10 Nichiban Co., Ltd. Adhesive skin patch
JP6290521B1 (ja) * 2016-09-16 2018-03-07 ニチバン株式会社 貼付剤
WO2019146614A1 (ja) 2018-01-24 2019-08-01 久光製薬株式会社 貼付剤
JP7179212B1 (ja) 2022-05-02 2022-11-28 久光製薬株式会社 リドカイン含有貼付剤

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE451669C (sv) 1984-02-17 1989-08-14 Moelnlycke Ab Kompress innehaallande zinkoxid
IL86170A (en) 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE69009540T2 (de) 1989-03-15 1994-09-29 Nitto Denko Corp Arzneimittel enthaltendes Heftpflaster.
CA1338779C (en) 1989-03-17 1996-12-10 Harry Hind Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
US5411738A (en) 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
US5098417A (en) 1990-04-12 1992-03-24 Ricoh Kyosan, Inc. Cellulosic wound dressing with an active agent ionically absorbed thereon
JP3115625B2 (ja) 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
DE69228313T2 (de) 1991-08-30 1999-09-23 Hisamitsu Pharmaceutical Co Entzündungshemmendes, analgetisches pflaster
US5804213A (en) 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
DE4224325C1 (de) 1992-07-23 1994-02-10 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster für niedrigschmelzende und/oder flüchtige Wirkstoffe und Verfahren zu seiner Herstellung
US6315772B1 (en) 1993-09-24 2001-11-13 Transmedica International, Inc. Laser assisted pharmaceutical delivery and fluid removal
JPH07215850A (ja) 1994-02-04 1995-08-15 Sekisui Chem Co Ltd 局所麻酔用経皮吸収テープ
US5536263A (en) 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
IL113034A (en) 1994-04-05 2000-02-17 Astra Ab Topical dressing
US5618274A (en) 1994-04-08 1997-04-08 Rosenthal; Kenneth J. Method and device for deep pressurized topical, fornix applied "nerve block" anesthesia
SE9401620L (sv) 1994-05-10 1996-01-10 Alpharma Ab Kombinerad användning av lokalbedövningsmedel och täckande förband
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US6245347B1 (en) 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US6461644B1 (en) 1996-03-25 2002-10-08 Richard R. Jackson Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods
FR2748207B1 (fr) 1996-05-06 1998-06-12 Cird Galderma Composition a base d'un compose modulant la reactivite des fibres nerveuses
JPH09315964A (ja) 1996-05-27 1997-12-09 Chinhin Boku 肩こり・五十肩治療用貼付剤
IL127955A0 (en) 1996-07-11 1999-11-30 Farmarc Nederland Bv Pharmaceutical composition containing acid addition salt of basic drug
US6365178B1 (en) 1996-09-06 2002-04-02 Watson Pharmaceuticals, Inc. Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions
US5985317A (en) 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
JPH10147521A (ja) 1996-09-18 1998-06-02 Yuutoku Yakuhin Kogyo Kk 持続性疼痛緩和用貼付剤
AU4321297A (en) 1996-10-04 1998-04-24 Saitama Daiichi Seiyaku Kabushiki Kaisha Patch
JPH1149670A (ja) 1997-08-04 1999-02-23 Nichiban Co Ltd 局所麻酔用経皮吸収型製剤
US5891919A (en) 1997-09-19 1999-04-06 Burlington Bio-Medical & Scientific Corp. Denatonium capsaicinate and methods of producing the same
EP1021204B1 (en) * 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
FR2770843B1 (fr) 1997-11-13 2000-01-14 Lavipharm Lab Association prolamines-lipides polaires vegetaux, son procede de preparation et ses applications
US6120792A (en) 1998-04-29 2000-09-19 Juni; Jack E. Medicated skin patch and method for its use
US6264927B1 (en) 1998-08-27 2001-07-24 Elmer P. Monahan Topical solution and method for the treatment of nail fungus
EP1125578A4 (en) * 1998-10-05 2006-05-03 Yutoku Pharmaceutical Ind Co L TAPE FOR PERCUTANEOUS ABSORPTION
JP3159688B2 (ja) 1998-10-05 2001-04-23 祐徳薬品工業株式会社 経皮吸収テープ剤
US7127285B2 (en) 1999-03-12 2006-10-24 Transport Pharmaceuticals Inc. Systems and methods for electrokinetic delivery of a substance
US6689380B1 (en) 1999-05-17 2004-02-10 Kevin S. Marchitto Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
US6299902B1 (en) 1999-05-19 2001-10-09 The University Of Georgia Research Foundation, Inc. Enhanced transdermal anesthesia of local anesthetic agents
US6580011B1 (en) 1999-07-29 2003-06-17 Barbara Jennings-Spring Circumcision/penile dressing
US6528086B2 (en) 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
US6383511B1 (en) 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US6264981B1 (en) 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US6469227B1 (en) 1999-12-10 2002-10-22 Lectec Corporation Antipruritic patch
ATE353636T1 (de) 1999-12-15 2007-03-15 Hisamitsu Pharmaceutical Co Adhäsive zubereitungen
US6455066B1 (en) 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
JP2001302501A (ja) 2000-04-17 2001-10-31 Oishi Koseido:Kk 肩こり・膝関節痛・五十肩等の治療用貼付剤
JP2004512260A (ja) 2000-04-28 2004-04-22 メモリアル　スローン−ケッタリング　キャンサー　センター 局所麻酔／オピオイド製剤およびその使用方法
AU2001264256B2 (en) 2000-06-13 2006-05-11 Hisamitsu Pharmaceutical Co, Inc Plaster
GB0015617D0 (en) 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
JP4787397B2 (ja) 2000-08-28 2011-10-05 日東電工株式会社 粘着剤組成物および粘着テープもしくはシート
US7288265B1 (en) 2000-10-16 2007-10-30 Lectec Corporation Treating viral infection at smallpox vaccination site
TWI287455B (en) 2000-12-05 2007-10-01 Noven Pharma Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
US6830758B2 (en) 2001-04-02 2004-12-14 Lectec Corporation Psoriasis patch
US7094228B2 (en) 2001-07-31 2006-08-22 Zars, Inc. Methods and formulations for photodynamic therapy
US20030124174A1 (en) 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
JP2003137773A (ja) 2001-10-31 2003-05-14 Hisamitsu Pharmaceut Co Inc 積層支持体を有する貼付剤
TWI312885B (en) 2001-12-06 2009-08-01 Nec Lcd Technologies Ltd Semi-transmissive liquid crystal display device
GB2382778B (en) 2001-12-07 2005-02-16 Blatchford & Sons Ltd An orthotic strut component
US7921999B1 (en) 2001-12-20 2011-04-12 Watson Laboratories, Inc. Peelable pouch for transdermal patch and method for packaging
JP2003191659A (ja) 2001-12-25 2003-07-09 Fuji Photo Film Co Ltd 平版印刷版用アルミニウム支持体とその製造方法、および平版印刷原版
EP1477164B1 (en) * 2002-02-19 2012-06-06 Hisamitsu Pharmaceutical Co. Inc. Percutaneous absorption type plaster
JP4792193B2 (ja) 2002-08-28 2011-10-12 久光製薬株式会社 貼付剤
US7166641B2 (en) 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
US20040076671A1 (en) 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
US7993654B2 (en) 2002-12-23 2011-08-09 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract
DE10260873A1 (de) 2002-12-23 2004-07-15 Beiersdorf Ag Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
EP2918296A1 (en) 2003-02-28 2015-09-16 Biointeractions Ltd. Polymeric network system for medical devices and methods of use
US7179477B2 (en) 2003-08-15 2007-02-20 Shyam K Gupta Cosmetic dermabrasion treatment system
US6998109B1 (en) 2004-01-07 2006-02-14 Pearson Research & Development Limited Emu-based formulations with lidocaine for wound treatment by inhibiting microbial activity
CN1909929B (zh) 2004-01-29 2011-04-20 美德阿利克斯株式会社 消炎镇痛外用药
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
WO2006017632A1 (en) 2004-08-04 2006-02-16 Cassel Douglas R An analgesic patch for sports injury and rehabilitation medicine and method to alleviate pain
ES2596809T3 (es) 2004-10-08 2017-01-12 Noven Pharmaceuticals, Inc. Dispositivo de administración transdérmica de fármacos que incluye un refuerzo oclusivo
EP1959931A4 (en) * 2005-12-14 2012-08-22 Zars Pharma Inc COMPOSITIONS AND METHODS FOR THE DERMAL TREATMENT OF PAIN
JP5037831B2 (ja) 2006-02-15 2012-10-03 久光製薬株式会社 凝集力向上及び徐放化の外用貼付剤
US7695733B2 (en) 2006-02-17 2010-04-13 Zasler Nathan D Application of topical anesthetics for modulation of neurogenic tremor
US7910135B2 (en) 2006-10-13 2011-03-22 Uluru Inc. Hydrogel wound dressing and biomaterials formed in situ and their uses
US20100003313A1 (en) 2006-10-27 2010-01-07 Hisamitsu Pharmaceutical Co.,Inc. Adhesive skin patch
US7904146B2 (en) 2006-11-13 2011-03-08 Travanti Pharma Inc. Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions
US8236417B2 (en) 2006-12-01 2012-08-07 Kuraray Co., Ltd. Pressure-sensitive adhesive for optical films
JP5360751B2 (ja) 2007-01-29 2013-12-04 株式会社 メドレックス 非ステロイド系抗炎症薬と有機アミン化合物との塩とその用途
US8722065B2 (en) 2007-11-11 2014-05-13 Medrx Co., Ltd. Lidocaine tape preparation
JP5130026B2 (ja) 2007-11-16 2013-01-30 日東電工株式会社 貼付剤および貼付製剤
US20090297591A1 (en) 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
US8231906B2 (en) 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
EP2311498A4 (en) 2008-08-05 2013-07-24 Medrx Co Ltd EXTERNAL PREPARATION COMPRISING A FATTY ACID SALT OR A BENZOIC ACID SALT OF A PHARMACOLOGICALLY ACTIVE BASIC COMPONENT, AND PROCESS FOR PRODUCTION THEREOF
US20100092544A1 (en) 2008-10-14 2010-04-15 Katsuhiro Okada Adhesive composition for patch and use thereof
WO2010146872A1 (ja) 2009-06-19 2010-12-23 株式会社メドレックス アリピプラゾールと有機酸を有効成分とする外用剤組成物
WO2011010645A1 (ja) 2009-07-24 2011-01-27 帝國製薬株式会社 フェンタニル含有外用貼付剤
TWI482645B (zh) 2010-01-07 2015-05-01 Teikoku Seiyaku Kk 含有待克菲那（ｄｉｃｌｏｆｅｎａｃ）羥乙基吡咯啶之外用油性敷貼劑
MX368747B (es) 2011-05-10 2019-10-14 Itochu Chemical Frontier Corp Parche no acuoso de lidocaína y un agente de disolución que comprende un ácido orgánico y un polialcohol que están contenidos en un emplaste para usarse en el tratamiento de dolor muscular a través de la piel.
US9925264B2 (en) * 2011-05-10 2018-03-27 Itochu Chemical Frontier Corporation Non-aqueous patch
JP6021269B2 (ja) 2011-09-27 2016-11-09 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤
AU2016312038A1 (en) 2015-08-24 2018-03-15 Itochu Chemical Frontier Corporation Non-aqueous patch comprising lidocaine
WO2019220420A1 (en) 2018-05-18 2019-11-21 Pedranti William Non-aqueous patch with superior adhesion characteristics

Also Published As

Publication number Publication date
MX368747B (es) 2019-10-14
EP2708229A1 (en) 2014-03-19
EP2708229A4 (en) 2014-11-19
US9283174B2 (en) 2016-03-15
EP3569227A1 (en) 2019-11-20
US11278623B2 (en) 2022-03-22
BR112013028802A2 (pt) 2018-06-12
TWI543761B (zh) 2016-08-01
JPWO2012153396A1 (ja) 2014-07-28
BR112013028802B1 (pt) 2021-10-26
CA2835595A1 (en) 2012-11-15
JP5856153B2 (ja) 2016-02-09
CA2835595C (en) 2019-02-12
MX2013013121A (es) 2014-08-26
US20210077626A1 (en) 2021-03-18
BR122021017591B1 (pt) 2022-05-10
US20140171509A1 (en) 2014-06-19
TW201249431A (en) 2012-12-16
EP2708229B1 (en) 2019-07-31
WO2012153396A1 (ja) 2012-11-15
ES2743524T3 (es) 2020-02-19

Similar Documents

Publication Publication Date Title
MX368747B (es) Parche no acuoso de lidocaína y un agente de disolución que comprende un ácido orgánico y un polialcohol que están contenidos en un emplaste para usarse en el tratamiento de dolor muscular a través de la piel.
AU2018282098A8 (en) Inhibition of crystal growth of roflumilast
PH12015500561A1 (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
MX349383B (es) Formulaciones para el tratamiento de diabetes.
MX349992B (es) Composiciones de alta concentracion de alfa-glucosidasa para el tratamiento de la enfermedad de pompe.
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
MX2015000990A (es) Analogos del glucagon.
MY180145A (en) Cenicriviroc compositions and methods of making and using the same
MX2021013880A (es) Polimeros enlazados al proton para administracion oral.
EA201290859A1 (ru) Лечение люпус-артрита с использованием лаквинимода
IN2014MN01962A (es)
MX338554B (es) Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor.
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof
MX2012005689A (es) Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos.
MX2014004652A (es) Composicion medica de eperisona estabilizada, y preparacion de liberacion sostenida que contiene la misma.
IN2012DN05192A (es)
MX354697B (es) Composiciones de gel de brimonidina y métodos de uso.
MX2016001607A (es) Microesferas de entecavir y composicion farmaceutica para administracion parenteral que contiene las mismas.
EA201490045A1 (ru) Дейтерированные 1-пиперазино-3-фенилинданы, применяемые для лечения шизофрении
MX2012007225A (es) Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
PH12014502407A1 (en) New alfentanil composition for the treatment of acute pain
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
UA112327C2 (uk) Біциклічна гетероциклічна сполука
MX2016011152A (es) Parche transdermico que contiene pramipexol para tratamiento de enfermedad neurodegenerativa.
MX2016007370A (es) Agente terapeutico y/o preventivo que comprende un derivado de 1-indansulfamida para el dolor.

Legal Events

Date Code Title Description
FG Grant or registration